In preclinical and phase 1 ... who had treatment-resistant hypertension, with blood pressure of 130/80 mm Hg or higher, and who were receiving stable doses of at least three antihypertensive ...

8-10 In the phase 2 PULSAR trial, which involved 106 patients receiving background therapy for pulmonary arterial hypertension, 24 weeks of treatment ... to its role in the design of the trial ...

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ... including benefits in both progression-free and overall survival in frontline treatment, and we continue to observe strong ...

Aura Biosciences announced that it has received an agreement from the FDA under a special protocol assessment for the design of a phase 3 trial ... for bel-sar for the treatment of early-stage ...

Recovery was more likely for people treated with conformal, or highly targeted, radiation techniques, compared to standard whole-brain treatment ... in three large, randomized phase III clinical ...